0000000001104729

AUTHOR

Carmelo Buda

showing 4 related works from this author

Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, prag…

2019

Chronic intestinal disorders (CID), including inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn’s disease, irritable bowel syndrome (IBS), and diverticular disease (DD), are diseases that relapse episodes. There is evidence that patients with CID have intestinal dysbiosis, so probiotics may counterbalance the impaired microbiota. Therefore, the current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 3,460…

Diverticular DiseasesMaleirritable bowel syndromeLactobacillus delbrueckiiProbioticsdiverticular diseaseAdministration OralInflammatory bowel disease irritable bowel syndrome diverticular disease probiotic surveyMiddle AgedInflammatory Bowel DiseasesLactobacillusinflammatory bowel diseaseChronic DiseaseDietary SupplementsHumansFemaleOriginal ArticlesurveySelf ReportprobioticLactobacillus plantarumActa bio-medica : Atenei Parmensis
researchProduct

Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel prepa…

2019

Bowel preparation (BP) for colonoscopy induces significantly changes in gut microbiota and elicit intestinal symptoms. Impaired microbiota causes an intestinal dysbiosis. Consequently, probiotics may counterbalance the disturbed microbiota after BP. The current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 2,979 outpatients (1,579 males and 1,400 females, mean age 56 years) undergoing BP. Patients took 1 stick/daily for 4 w…

MaleLactobacillus delbrueckiigut microbiotaProbioticsColonoscopyMiddle AgedLactobacillusPreoperative Carebowel preparationDysbiosisHumansFemaleOriginal Articlesurveybowel preparation gut microbiota colonoscopy probiotics surveyLactobacillus plantarumActa bio-medica : Atenei Parmensis
researchProduct

Th17 skewing in the GALT of a Crohn disease patient upon Lactobacillus rhamnosus GG consumption.

2015

We wish to report on a recent observation we made and that might represent a useful hint for the employment of the so called probiotics in the management of some pathological immune reactions of the gut. By analyzing GALT-associated T cells upon consumption of L. rhamnosus-GG, we obtained some hints that probiotics might have locoregional immunological effects mainly when administered in patients with IBDs rather than in individuals with non-inflamed gut mucosa.

0301 basic medicineSettore MED/17 - Malattie InfettiveImmunologyBioinformaticsPeyer's PatcheProbioticInflammatory bowel diseaseTh17 Cell03 medical and health sciencesPeyer's Patches0302 clinical medicineLactobacillus rhamnosusCrohn DiseaseIntestinal mucosaImmunology and AllergyMedicineHumansConsumption (economics)Settore MED/04 - Patologia Generalebiologybusiness.industryCrohn diseaseLacticaseibacillus rhamnosusInflammatory bowel disease; Intestinal mucosa; Lactobacillus rhamnosus; Mucosal barrier; Probiotics; T cell polarizationProbioticsbiology.organism_classificationMucosal barrierT cell polarization030104 developmental biology030220 oncology & carcinogenesisImmunologyTh17 CellsLactobacillus rhamnosubusinessHumanImmunology letters
researchProduct

Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lacto…

2019

Abdominal surgery represents a high risk for hospital-acquired infections and complication that may compromise the surgery outcome. Patients with recent abdominal surgery have an intestinal dysbiosis. There is evidence that probiotics may counterbalance the impaired microbiota. Therefore, the current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 612 outpatients (344 males and 268 females, mean age 58 years) undergoing diges…

MaleLactobacillus delbrueckiiProbioticsDigestive surgery dysbiosis microbiota probiotic surveydysbiosisMiddle AgedGastrointestinal MicrobiomeLactobacillusPostoperative ComplicationsTreatment OutcomeAbdomenmicrobiotaHumansdigestive surgeryFemaleOriginal ArticlesurveyprobioticLactobacillus plantarumActa bio-medica : Atenei Parmensis
researchProduct